image
Healthcare - Biotechnology - NASDAQ - US
$ 46.75
-26.6 %
$ 4.59 B
Market Cap
19.98
P/E
BALANCE SHEET
3.96 B ASSETS
21.40%
2.44 B LIABILITIES
1.26%
1.53 B EQUITY
77.78%
BALANCE SHEET DECOMPOSITION
Balance Sheet Sarepta Therapeutics, Inc.
image
Current Assets 3.07 B
Cash & Short-Term Investments 1.35 B
Receivables 650 M
Other Current Assets 1.07 B
Non-Current Assets 890 M
Long-Term Investments 133 M
PP&E 489 M
Other Non-Current Assets 268 M
34.18 %16.39 %26.97 %3.36 %12.33 %6.76 %Total Assets$4.0b
Current Liabilities 732 M
Accounts Payable 214 M
Short-Term Debt 0
Other Current Liabilities 517 M
Non-Current Liabilities 1.7 B
Long-Term Debt 1.14 B
Other Non-Current Liabilities 567 M
8.81 %21.24 %46.69 %23.27 %Total Liabilities$2.4b

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998 Dec-1997 Dec-1996 Dec-1995
ASSETS
Cash & Cash Equivalents 1 103.0 428.4 966.8 2 115.9 1 502.6 835.1 370.8 599.7 122.4 80.3 73.6 257.0 187.7 39.9 33.6 48.3 11.2 24.8 20.2 34.6 16.7 12.5 10.4 11.1 25.9 8.7 8.5 17.6 3.0 0.7
Short Term Investments 251.8 1 247.8 1 022.6 0 435.9 289.7 803.1 479.4 195.4 112.2 136.8 0 0 0 0 0.2 0.3 0.3 13.0 12.5 2.9 25.1 8.9 14.5 6.2 2.9 0 0 0 0.2
Receivables 649.7 439.7 259.7 171.6 135.5 90.9 49.0 29.5 5.2 4.0 2.4 3.5 4.7 3.6 3.2 2.1 5.0 2.9 51.5 K 1.2 0 0 0 0 0 0 0 0 0 0
Inventory 750.0 322.9 204.0 186.2 232.0 171.4 125.4 83.6 12.8 26.9 33.5 7.2 1 (3.6) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 319.0 140.5 108.1 224.0 179.1 81.9 77.8 36.5 37.6 28.1 35.0 10.3 1.5 1.6 1.0 1.3 0.3 0.8 0.7 0.4 0.7 0.8 1.1 1.9 1.0 100 K 0.5 100 K 0 0
Total Current Assets 3 073.5 2 579.3 2 557.9 2 604.1 2 485.2 1 468.9 1 426.2 1 228.6 373.5 224.5 247.8 270.8 193.9 45.2 37.8 51.3 17.0 28.7 33.9 48.7 20.2 38.4 20.4 27.5 33.1 11.7 9.0 17.7 3.0 0.9
PP&E 488.6 357.1 245.0 236.7 282.2 167.6 97.0 43.2 37.8 37.3 38.5 15.0 3.4 4.3 4.0 2.5 5.2 6.8 4.3 5.6 6.3 7.0 6.6 4.9 1.0 0.4 0.4 0.4 0.5 0.9
Intangible Assets 26.9 29.6 7.6 14.2 13.6 12.5 11.6 14.4 8.1 6.6 5.9 5.0 4.9 4.8 4.0 3.8 3.3 3.1 2.6 2.1 2.0 1.7 1.6 1.4 0.9 0.8 0.7 0.6 0 0.4
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 133.2 6.5 31.3 34.9 38.8 31.9 107.3 10.0 0.8 0.8 0 0.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 241.0 292.0 286.6 143.3 13.0 11.8 107.3 21.8 4.8 5.3 2.8 25 K 2.8 0.2 0.1 2.5 34.7 K 34.7 K 34.7 K 37.6 K 37.6 K 29.8 K 29.8 K 29.8 K 29.8 K 0 100 K 100 K 0.7 100 K
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 3 963.2 3 264.6 3 128.4 3 148.0 2 984.7 1 822.8 1 642.1 1 308.0 424.1 273.8 295.0 291.6 205.0 54.4 46.0 60.0 25.5 38.6 40.9 56.4 28.5 47.1 28.6 33.8 35.1 12.9 10.2 18.8 4.2 2.3
LIABILITIES
Accounts Payable 214.4 164.9 95.9 76.7 111.1 68.1 33.8 8.5 29.7 20.2 12.4 17.6 7.5 9.4 1.3 1.4 2.0 3.0 1.4 1.9 1.5 3.1 4.5 2.8 1.3 0.7 0.9 0.2 0.2 100 K
Short Term Debt 0 123.3 15.5 0 0 0 0 6.2 10.1 8.4 2.6 (9.5) 89 K 85 K 81 K 77 K 73.7 K 71.1 K 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 369.6 301.2 406.5 286.5 215.7 196.7 136.3 69.4 32.3 30.3 18.6 14.9 68.0 7.8 41.2 28.6 3.0 5.9 1.7 0.9 0.8 0.7 0.6 0.5 0.4 0.3 0.3 0.3 100 K 0.2
Total Current Liabilities 731.7 653.7 619.6 452.7 416.0 264.8 173.7 88.3 75.4 62.3 36.9 36.0 78.9 20.6 45.9 33.5 7.3 9.8 3.2 2.7 2.2 3.8 5.1 3.3 1.7 1.0 1.2 0.5 0.3 0.3
Long Term Debt 1 137.1 1 273.5 1 601.9 1 138.4 1 072.9 729.6 420.6 424.9 6.0 15.0 3.7 1.6 1.7 1.8 1.8 1.9 2.0 2.1 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 566.6 41.1 36.9 54.6 70.6 10.2 15.6 5.5 5.9 6.2 6.8 6.8 0.8 1.0 1.1 1.0 0.5 0.4 0 0 0 0 0 0 0 0 0 0 3.1 0
Total Liabilities 2 435.4 2 405.2 2 743.4 2 220.0 2 223.0 1 004.6 609.8 518.7 87.4 83.4 47.4 44.4 81.3 23.4 48.8 36.4 9.8 12.3 3.2 2.7 2.2 3.8 5.1 3.3 1.7 1.0 1.2 0.5 3.4 0.3
EQUITY
Common Stock 10 K 9 K 9 K 9 K 8 K 8 K 7 K 6 K 5 K 5 K 4 K 4 K 3 K 13 K 11 K 11 K 7.11 K 6.44 K 5.32 K 5.12 K 3.61 K 3.45 K 2.66 K 2.32 K 2.15 K 0 0 0 0 3.1
Retained Earnings (4 211.0) (4 446.2) (3 910.2) (3 206.7) (2 848.1) (2 294.0) (1 578.9) (1 217.0) (1 166.3) (899.1) (679.0) (543.2) (431.3) (310.0) (307.6) (275.5) (250.3) (226.4) (203.7) (172.6) (156.0) (131.2) (116.6) (87.2) (60.3) (51.1) (42.8) (16.0) (12.4) (10.3)
Other Accumulative Comprehensive Income/Loss (0.2) 0.9 (1.7) 20 K 3 K 50 K 99 K (0.4) (0.1) (0.1) 95 K (17.3) (16.7) (15.8) (15.0) (14.0) (12.9) (11.8) 18.4 K 13 K (0.1) (0.3) 0.7 1.0 (11.7) (2.5) (2.4) (2.3) (1.9) 100 K
Total Equity 1 527.7 859.3 384.9 928.0 761.8 818.2 1 032.3 789.2 336.7 190.3 247.7 247.2 123.7 31.0 (2.8) 23.6 15.7 26.4 37.7 53.7 26.3 43.4 23.5 30.5 33.4 11.9 9.0 18.3 0.8 2.1
Total Liabilities and Equity 3 963.2 3 264.6 3 128.4 3 148.0 2 984.7 1 822.8 1 642.1 1 308.0 424.1 273.8 295.0 291.6 205.0 54.4 46.0 60.0 25.5 38.6 40.9 56.4 28.5 47.1 28.6 33.8 35.1 12.9 10.2 18.8 4.2 2.4
SHARES OUTSTANDING
Common Shares Outstanding 95.1 92.4 87.6 81.3 78.0 73.6 66.2 58.8 48.7 42.3 40.0 33.8 23.6 21.6 18.5 15.5 11.6 9.0 8.8 7.4 6.0 5.0 4.3 3.7 3.1 2.2 2.0 1.7 1.4 1.2